Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab-Reference-Cited by-同舟云学术

Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab

Published:2022-12-01 Issue:6 Volume:187 Page:1028-1030
ISSN:1365-2133
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

van der Schoot Lara S.¹²^ORCID,Atalay Selma¹^ORCID,Otero Marisol E.¹^ORCID,Kievit Wietske³^ORCID,van den Reek Juul M.P.A.¹²^ORCID,de Jong Elke M.G.J.¹⁴^ORCID

Affiliation:

1. Department of Dermatology Radboud University Medical Center Nijmegen the Netherlands

2. Radboud Institute for Health Sciences Radboud University Medical Center Nijmegen the Netherlands

3. Department for Health Evidence Radboud University Medical Center Nijmegen the Netherlands

4. Radboud University Nijmegen the Netherlands

Funder

AbbVie

Almirall

Eli Lilly and Company

Janssen Pharmaceuticals

LEO Pharma Research Foundation

Novartis

Pfizer

UCB

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.21797

Reference8 articles.

1. Dose tapering of biologics in patients with psoriasis: a scoping review;Michielsens;Drugs,2021

2. Comparison of tightly controlled dose reduction of biologics with usual care for patients with psoriasis: a randomized clinical trial;Atalay;JAMA Dermatol,2020

3. Health economic consequences of a tightly controlled dose reduction strategy for adalimumab, etanercept and ustekinumab compared with standard psoriasis care: a cost-utility analysis of the CONDOR study;Atalay;Acta Derm Venereol,2020

4. Evaluation of a one-step dose reduction strategy for adalimumab, etanercept and ustekinumab in patients with psoriasis in daily practice;Atalay;Acta Derm Venereol,2021

5. ‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network;van den Reek;Br J Dermatol,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose reduction of biologics in patients with plaque psoriasis: a review;Frontiers in Pharmacology;2024-03-28

2. Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice;Journal of Dermatological Treatment;2023-03-13